2015
DOI: 10.1371/journal.pone.0136189
|View full text |Cite
|
Sign up to set email alerts
|

Partially Protective Immunity Induced by a 20 kDa Protein Secreted by Trichinella spiralis Stichocytes

Abstract: Background Trichinella spiralis infection induces protective immunity against re-infection in animal models. Identification of the antigens eliciting acquired immunity during infection is important for vaccine development against Trichinella infection and immunodiagnosis.Methods and FindingsThe T. spiralis adult cDNA library was immunoscreened with sera from pigs experimentally infected with 20,000 infective T. spiralis larvae. Total 43 positive clones encoding for 28 proteins were identified; one of the immun… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
15
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
3

Relationship

2
7

Authors

Journals

citations
Cited by 24 publications
(18 citation statements)
references
References 58 publications
1
15
0
Order By: Relevance
“…Firstly, a combination of T- and B-cell epitopes may enhance the induction of both cell-mediated and humoral immune responses. It has been proved that a mixed humoral and cellular immune response contributed to the protective immunity against T. spiralis infection ( Bi et al, 2015 ; Liu et al, 2015 ). Secondly, the strategy involves positioning T cell epitopes on the N-terminal side and B-cell epitopes on the C-terminal side separated each epitope by a di-lysine linker.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Firstly, a combination of T- and B-cell epitopes may enhance the induction of both cell-mediated and humoral immune responses. It has been proved that a mixed humoral and cellular immune response contributed to the protective immunity against T. spiralis infection ( Bi et al, 2015 ; Liu et al, 2015 ). Secondly, the strategy involves positioning T cell epitopes on the N-terminal side and B-cell epitopes on the C-terminal side separated each epitope by a di-lysine linker.…”
Section: Discussionmentioning
confidence: 99%
“…During the past decades, many vaccine candidates against Trichinellosis have been investigated and reported, including those based on crude larval extracts ( Deville et al, 2005 ), excretory-secretory (ES) products ( Dea-Ayuela et al, 2006 ), DNA ( Wang et al, 2016 ), recombinant proteins ( Bi et al, 2015 ), peptides ( Castillo et al, 2013 ) or combined DNA with protein ( Gu et al, 2014 ), all of them induced different extents of partial protective immunity in animal models. However, due to the complexity of the life cycle, diversity of stage-specific antigens and immune-evasion strategies of T. spiralis ( Zhang et al, 2011 ; Sun et al, 2015 ), researchers face the challenges in developing effective vaccines against Trichinellosis.…”
Section: Introductionmentioning
confidence: 99%
“…Here, we mainly review the protective immunity against T. spiralis infection elicited from the crude mixed ES products and those uncharacterized components with a certain size in ES products (Table ). By now, the crude ES antigens at the certain molecular size of 20 kDa, 43 kDa, 53 kDa, 48 kDa, 49 kDa and 50/55 kDa have been investigated as immunogens against T. spiralis infection (Bi et al., ; Lightowlers & Rickard, ; Nagano, Wu, & Takahashi, ; Robinson, Bellaby, Chan, & Wakelin, ). All of them showed effective immune efficacies in reduction in the worm burden.…”
Section: Candidate Antigensmentioning
confidence: 99%
“…The surface protein 28.9 kDa (Ts14-3-3) [34], the E/S protein of 35.5 kDa (TspSP1.2) [35], 54.7 kDa amino peptidase (TsAP) also expressed by adult worms and NBL, located primarily at the cuticle and internal organs of the parasite [36], the protein of 20 kDa (Ts-ES-1) existing in the E/S products of T. spiralis adult and ML [37], and paramyosin (Ts-Pmy) [38] among others have been tested in mice. In all cases, partial protection assessed against the enteral and muscle phase of the infection was elicited (35-55%).…”
Section: Second-generation Vaccinesmentioning
confidence: 99%